{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:20:50Z","timestamp":1793136050776,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012618","name":"National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.ajo.2011.03.013","type":"journal-article","created":{"date-parts":[[2011,6,6]],"date-time":"2011-06-06T16:29:58Z","timestamp":1307377798000},"page":"10-15.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Anti\u2013Vascular Endothelial Growth Factor Therapy in Glaucoma Filtration Surgery"],"prefix":"10.1016","volume":"152","author":[{"given":"Rashmi","family":"Mathew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajo.2011.03.013_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0039-6257(87)90091-9","article-title":"Wound healing in glaucoma filtering surgery","volume":"32","author":"Skuta","year":"1987","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2011.03.013_bib2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1006\/exer.1994.1037","article-title":"Modulation of human fibroblast activity by selected angiogenesis inhibitors","volume":"58","author":"Wong","year":"1994","journal-title":"Exp Eye Res"},{"issue":"4","key":"10.1016\/j.ajo.2011.03.013_bib3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/archopht.116.4.443","article-title":"Late-onset bleb leaks after glaucoma filtering surgery","volume":"116","author":"Greenfield","year":"1998","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2011.03.013_bib4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/bjo.2005.077800","article-title":"Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks","volume":"90","author":"Anand","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2011.03.013_bib5","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/archopht.1996.01100140151007","article-title":"Endophthalmitis after filtering surgery with mitomycin","volume":"114","author":"Greenfield","year":"1996","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2011.03.013_bib6","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0161-6420(96)30639-8","article-title":"Bleb-related endophthalmitis after trabeculectomy with mitomycin C","volume":"103","author":"Higginbotham","year":"1996","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2011.03.013_bib7","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0002-9394(00)00901-6","article-title":"Glaucoma filtering bleb dysesthesia","volume":"131","author":"Budenz","year":"2001","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2011.03.013_bib8","first-page":"1445","article-title":"Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing","volume":"152","author":"Nissen","year":"1998","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.ajo.2011.03.013_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/bjs.4453","article-title":"Increased vascular endothelial growth factor production in fibroblasts isolated from strictures in patients with Crohn's disease","volume":"91","author":"Beddy","year":"2004","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.ajo.2011.03.013_bib10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/labinvest.2008.36","article-title":"Regulation of scar formation by vascular endothelial growth factor","volume":"88","author":"Wilgus","year":"2008","journal-title":"Lab Invest"},{"issue":"6","key":"10.1016\/j.ajo.2011.03.013_bib11","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.ajo.2011.03.013_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jso.20938","article-title":"\u201cSpontaneous,\u201d delayed colon and rectal anastomotic complications associated with bevacizumab therapy","volume":"97","author":"August","year":"2008","journal-title":"J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ajo.2011.03.013_bib13","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0161-6420(98)92782-8","article-title":"Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma","volume":"105","author":"Tripathi","year":"1998","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2011.03.013_bib14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/00061198-200210000-00006","article-title":"Vascular endothelial growth factor is increased in aqueous humor of glaucomatous eyes","volume":"11","author":"Hu","year":"2002","journal-title":"J Glaucoma"},{"issue":"11","key":"10.1016\/j.ajo.2011.03.013_bib15","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1167\/iovs.08-2662","article-title":"Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery","volume":"50","author":"Li","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.ajo.2011.03.013_bib16","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1167\/iovs.04-0375","article-title":"Microarray analysis of the failure of filtering blebs in a rat model of glaucoma filtering surgery","volume":"45","author":"Esson","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2011.03.013_bib17","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1167\/iovs.09-4140","article-title":"Pharmacokinetics of bevacizumab and its effect on vascular endothelial growth factor after intravitreal injection of bevacizumab in macaque eyes","volume":"51","author":"Miyake","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.ajo.2011.03.013_bib18","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1167\/iovs.08-2441","article-title":"Postoperative use of bevacizumab as an antifibrotic agent in glaucoma filtration surgery in the rabbit","volume":"50","author":"Memarzadeh","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ajo.2011.03.013_bib19","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1167\/iovs.09-3949","article-title":"Combined treatment with bevacizumab and 5-fluorouracil attenuates the postoperative scarring response after experimental glaucoma filtration surgery","volume":"51","author":"How","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.ajo.2011.03.013_bib20","doi-asserted-by":"crossref","first-page":"6524","DOI":"10.1167\/iovs.10-5669","article-title":"Antifibrotic activity of bevacizumab on human Tenon's fibroblasts in vitro","volume":"51","author":"O'Neill","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.ajo.2011.03.013_bib21","first-page":"1186","article-title":"Transscleral delivery of bioactive protein to the choroid and retina","volume":"41","author":"Ambati","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.ajo.2011.03.013_bib22","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1167\/iovs.08-3148","article-title":"Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits","volume":"50","author":"Nomoto","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.ajo.2011.03.013_bib23","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ophtha.2007.01.017","article-title":"Pharmacokinetics of intravitreal bevacizumab (Avastin)","volume":"114","author":"Bakri","year":"2007","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2011.03.013_bib24","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.ophtha.2007.09.012","article-title":"Pharmacokinetics of intravitreal ranibizumab (Lucentis)","volume":"114","author":"Bakri","year":"2007","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2011.03.013_bib25","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ajo.2008.05.036","article-title":"Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans","volume":"146","author":"Krohne","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2011.03.013_bib26","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1755-3768.2008.01502.x","article-title":"Combined intravitreal bevacizumab and triamcinolone in exudative age-related macular degeneration","volume":"88","author":"Jonas","year":"2010","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2011.03.013_bib27","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.ophtha.2008.06.009","article-title":"Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy a pilot study","volume":"115","author":"Grewal","year":"2008","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2011.03.013_bib28","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ajo.2010.03.025","article-title":"Bleb morphology and vascularity after trabeculectomy with intravitreal ranibizumab: a pilot study","volume":"150","author":"Kahook","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2011.03.013_bib29","first-page":"1831","article-title":"Factors affecting the outcome of trabeculectomy: an analysis based on combined data from two phase III studies of an antibody to transforming growth factor \u03b22, CAT-152","volume":"114","year":"2010","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2011.03.013_bib30","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.ophtha.2007.03.050","article-title":"A phase III study of subconjunctival human anti-transforming growth factor \u03b22 monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy","volume":"114","year":"2007","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2011.03.013_bib31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0161-6420(01)00997-6","article-title":"Human antitransforming growth factor beta(2) monoclonal antibody\u2014a new modulator of wound healing in trabeculectomy: a randomized placebo controlled clinical study","volume":"109","author":"Siriwardena","year":"2002","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2011.03.013_bib32","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/IJG.0b013e31815f5345","article-title":"Vascular changes after intra-bleb injection of bevacizumab","volume":"17","author":"Coote","year":"2008","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajo.2011.03.013_bib33","article-title":"Topical bevacizumab is efficacious in the early bleb failure after trabeculectomy","author":"Zarnowski","year":"2009","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2011.03.013_bib34","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3928\/1542-8877-20060301-12","article-title":"Needle bleb revision of encapsulated filtering bleb with bevacizumab","volume":"37","author":"Kahook","year":"2006","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"8","key":"10.1016\/j.ajo.2011.03.013_bib35","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1167\/iovs.02-0978","article-title":"Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery","volume":"44","author":"Mead","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2011.03.013_bib36","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/bjo.84.1.92","article-title":"Sponge delivery variables and tissue levels of 5-fluorouracil","volume":"84","author":"Wilkins","year":"2000","journal-title":"Br J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939411002406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939411002406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:02:16Z","timestamp":1757595736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939411002406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0002939411002406"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2011.03.013","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti\u2013Vascular Endothelial Growth Factor Therapy in Glaucoma Filtration Surgery","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2011.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2011 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}